Search - tctmd.com

Displaying 21 - 40 of 455

Sort: Relevancy | Date

News Daily News

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Yael L. Maxwell

May 15, 2025

News Daily News

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

Caitlin E. Cox

April 28, 2025

News Conference News ACC 2025

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

Caitlin E. Cox

April 02, 2025

News Conference News ACC 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

Yael L. Maxwell

March 29, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Inconsistent Troponin Testing in US EDs Warrants Closer Look

Todd Neale

January 28, 2025

News Daily News

Mobile Health for Cardiac Rehab Doesn’t Aid Older Adults With CVD: RESILIENT

Caitlin E. Cox

January 15, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Conference News SCCT 2024

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Todd Neale

July 25, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Conference News ACC 2024

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

Shelley Wood

April 07, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

COVID-Related Decline in Acute CV Hospitalizations Sustained Through 2021

Todd Neale

January 09, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

Advertisement

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

WARRIOR: No Clear Answers on How to Best Treat INOCA

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Inconsistent Troponin Testing in US EDs Warrants Closer Look

Mobile Health for Cardiac Rehab Doesn’t Aid Older Adults With CVD: RESILIENT

November 2024 Dispatch for the CV Team

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

April 2024 Dispatch for the CV Team

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

COVID-Related Decline in Acute CV Hospitalizations Sustained Through 2021

Top Coronary Artery Disease News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content